Red blood cell and leukocyte alloimmunization in patients awaiting kidney transplantation
AUTOR(ES)
Silva, Silvia Fernandes Ribeiro da, Ferreira, Glaucia Maria, Silva, Sonia Leite da, Alves, T ania Maria de Oliveira, Ribeiro, Ilana Farias, Ribeiro, Thyciana Rodrigues, Cavalcante, Maria do Carmo Serpa
FONTE
Rev. Bras. Hematol. Hemoter.
DATA DE PUBLICAÇÃO
2013-06
RESUMO
Objective: To determine the rates of red blood cell and leukocyte alloimmunization in patients with chronic kidney disease awaiting kidney transplantation. Methods: In this cross-sectional and prospective study, the serum of 393 chronic kidney disease patients on a transplant waiting list in Ceará, Northeastern Brazil were tested for red cell and leukocyte antibodies. In addition, demographic, clinical and laboratory data were collected. Results: The average age in the sample of 393 patients was 34.1 ± 14 years. Slightly more than half (208; 52.9%) were male. The average numbers of transfusions and gestations were 3.1 ± 3.3 and 1.6 ± 6, respectively. One third (33.6%) were alloimmunized: 78% with leukocyte antibodies, 9.1% with red cell antibodies and 12.9% with both. Red cell antibodies were detected in 29 cases (7.4%), 17 of whom were women, who had received more transfusions than the males (p-value < 0.0001). The most frequently detected red cell antibodies belonged to the Rh (24.1%) and Kell (13.8%) blood group systems. Leukocyte antibodies were detected in 30.5% of cases, 83 of whom were women, who had received more transfusions than the males (p-value < 0.0001) and were more reactive to panel reactive antibodies (p-value < 0.0001). The mean alloreactivity to panel reactive antibodies was 47.7 ± 31.2%. Conclusion: Chronic kidney disease patients on the transplant waiting list in Ceará, Brazil, display high rates of red cell (7.4%) and leukocyte (30.5%) alloimmunization. In this sample, alloimmunization was significantly associated with the number of transfusions and gender.
Documentos Relacionados
- Red cell and human leukocyte antigen alloimmunization in candidates for renal transplantation: a reality
- The severity of illness and inflammatory markers cannot predict red blood cell alloimmunization in cancer patients
- Study of possible clinical and laboratory predictors of alloimmunization against red blood cell antigens in cancer patients
- Red blood cell storage and alloimmunization: a fact or a myth?
- Transfusion of older red blood cell units, cytokine burst and alloimmunization: a case-control study